The first medication for obstructive sleep apnea has been approved by the US Food and Drug Administration (FDA).

An international committee of experts will release an interim report in early 2025 outlining criteria for diagnosing ...

The Food and Drug Administration (FDA) announced the approval of the weight loss drug Zepbound, generically known as ...

The US Food and Drug Administration on Friday approved the first prescription medicine for obstructive sleep apnea: the ...

Branneisha Cooper was terrified of attending her first holiday gathering after starting Mounjaro. The 28-year-old ...

The United States Food and Drug Administration says the shortage of Eli Lilly’s Zepbound and Mounjaro drugs has been resolved ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 502.93% and ...

The weight loss medication tirzepatide (Mounjaro and Zepbound) is no longer in shortage, according to the FDA. Access to ...

The effects that a pause may have on your body may depend on why you're taking the medication in the first place.

Averaging up to 20% of weight loss, adults taking Zepbound had 25 fewer breathing interruptions each hour as they slept.